Pfizer and BioNTech to submit emergency use authorization request to FDA for COVID-19 vaccine
|Pfizer and BioNTech announced on Friday that they will be submitting an emergency use authorization request to the US Food and Drug Administration (FDA) on Friday.
Additional details of the announcement revealed that companies will be ready to distribute the vaccine within hours after the authorization.
"To date, Data Monitoring Committee (DMC) for the study has not reported any serious safety concerns related to the vaccine," Pfizer and BioNTech reiterated.
Market reaction
The S&P 500 Futures erased daily losses and turned flat at 3,578 ahead of the opening bell.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.